LMR is a marker of immune competence and systemic inflammation. Higher LMR values generally indicate better prognosis in cancer patients and lower cardiovascular risk. Low LMR suggests immune suppression or chronic inflammation. It's used for risk stratification in oncology and cardiovascular medicine.
LMR is a marker of immune competence and systemic inflammation. Higher LMR values generally indicate better prognosis in cancer patients and lower cardiovascular risk. Low LMR suggests immune suppression or chronic inflammation. It's used for risk stratification in oncology and cardiovascular medicine.
The Lymphocyte-to-Monocyte Ratio (LMR) reflects immune system balance and has prognostic value in various diseases, particularly cancer and cardiovascular disease.
Reference ranges may vary slightly between laboratories. The values below represent commonly accepted clinical ranges.
Ranges shown are general guidelines. Consult your provider for personalized interpretation.
| Biomarker | Reference range | Interpretation |
|---|---|---|
Lymphocyte-to-Monocyte Ratio (LMR) (Male — Standard) | 5–8 [pH] | Standard lab reference range |
Lymphocyte-to-Monocyte Ratio (LMR) (Female — Standard) | 5–8 [pH] | Standard lab reference range |
High Lymphocyte-to-Monocyte Ratio (LMR) levels above the standard range may indicate an underlying health condition that warrants further evaluation.
Low Lymphocyte-to-Monocyte Ratio (LMR) levels below the standard range may indicate an underlying health condition that warrants further evaluation.
The Lymphocyte-to-Monocyte Ratio (LMR) reflects immune system balance and has prognostic value in various diseases, particularly cancer and cardiovascular disease.
Standard range men: 5–8 [pH]; women: 5–8 [pH]. Always interpret ranges in clinical context, not as a stand-alone diagnosis.
LMR is a marker of immune competence and systemic inflammation. Higher LMR values generally indicate better prognosis in cancer patients and lower cardiovascular risk. Low LMR suggests immune suppression or chronic inflammation. It's used for risk stratification in oncology and cardiovascular medicine.
Low LMR: May be associated with fatigue, susceptibility to infections, poor wound healing, and symptoms of underlying conditions (cancer, chronic infection).
Low LMR: Cancer, chronic infections, autoimmune diseases, severe stress, malnutrition. High LMR: Generally indicates healthy immune function and lower disease burden.
Lymphocyte-to-Monocyte Ratio (LMR) can be ordered through Vitals Vault without a doctor referral, then completed at CLIA-certified Quest Diagnostics locations nationwide. After checkout, you receive clear draw instructions, digital requisition details, and a structured report that explains whether your result is in standard range, optimal range, or needs follow-up review.
Start by identifying the root cause, then use targeted nutrition, training, sleep, stress, and follow-up retesting to verify improvement. Lymphocyte-to-Monocyte Ratio (LMR) should be optimized with a personalized plan, not guesswork.
You should speak with a clinician if Lymphocyte-to-Monocyte Ratio (LMR) is significantly outside the reference range, trending in the wrong direction across repeat tests, or accompanied by symptoms like fatigue, chest discomfort, dizziness, weight change, or persistent inflammation signs. Immediate medical care is important for severe symptoms, not just abnormal numbers in isolation.
A practical retesting cadence for Lymphocyte-to-Monocyte Ratio (LMR) is every 8 to 12 weeks after major lifestyle, nutrition, or medication changes, and every 3 to 6 months for stable long-term tracking. Faster cadence is useful when values are clearly abnormal, while maintenance cadence helps confirm durability once results stabilize.
You can compare Essential ($99), Advanced ($199), and Max ($399) plans during checkout to confirm Lymphocyte-to-Monocyte Ratio (LMR) inclusion before purchasing. If Lymphocyte-to-Monocyte Ratio (LMR) is not in your selected tier, you can upgrade plans or add targeted testing so your panel matches your goals, symptoms, and retesting strategy.
Lymphocyte-to-Monocyte Ratio (LMR) is included in our comprehensive biomarker panels, processed at CLIA-certified Quest Diagnostics locations nationwide.
Foundation for a full basic health picture.
Deeper metabolic and nutritional insights.
Comprehensive testing for lifelong health.
Medical Disclaimer: This content is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition or treatment. Do not disregard professional medical advice or delay seeking it because of information presented here.